4.1 Article

Health-Related Quality of Life Experienced by Children With Chromosomal Abnormalities and Congenital Heart Defects

Journal

PEDIATRIC CARDIOLOGY
Volume 35, Issue 3, Pages 536-541

Publisher

SPRINGER
DOI: 10.1007/s00246-013-0820-3

Keywords

Congenital heart disease; Chromosomal abnormalities; Pediatric cardiac surgery; Health-related quality of life

Funding

  1. Registry and Follow-up of Complex Pediatric Therapies Project, Alberta Health and Wellness

Ask authors/readers for more resources

Long-term outcomes are fundamental in advising parents about the potential future of their children with congenital heart disease (CHD). No published reports have described the health-related quality of life (HRQL) experienced by children with chromosomal abnormalities who had surgery in early infancy for CHD. A study was undertaken to assess HRQL among children with chromosomal abnormalities and CHD. The authors hypothesized that these children have a worse HRQL than healthy children or a cohort of children matched for CHD diagnosis. Infants with chromosomal abnormalities undergoing cardiac surgery for CHD at 6 weeks of age or younger at the Stollery Children's Hospital between July 2000 and June 2005 were included in the study. The HRQL of these infants was assessed using the Pediatric Quality of Life Inventory (PedsQL) 4.0 Generic Core Scales completed by their parents at a 4-year follow-up evaluation. The study compared the scores for 16 children with normative data. The children with chromosomal abnormalities and CHD had significantly lower mean total PedsQL (71.3 vs. 87.3; p < 0.0001), Psychosocial Summary (70.3 vs. 86.1; p < 0.0001), and Physical Summary (74.3 vs. 89.2; p = 0.0006) scores. Compared with the matched children, those with chromosomal abnormalities had a significantly lower median total PedsQL (75.0 vs. 84.6; p = 0.03), Physical Summary (79.5 vs. 96.9; p = 0.007), and School Functioning (68.5 vs. 83.0; p = 0.03) scores. A better understanding of the mechanisms and determinants of HRQL in these children has the potential to yield important implications for clinical practice including clarity for treatment decision making as well as determination of targeted supports and services to meet the needs of these children and their families differentially.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.1
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Cardiac & Cardiovascular Systems

Fetal Umbilical Arterial Pulsatility Correlates With 2-Year Growth and Neurodevelopmental Outcomes in Congenital Heart Disease

Jayani B. Abeysekera, Dora L. Gyenes, Joseph Atallah, Charlene M. T. Robertson, Gwen Y. Bond, Ivan M. Rebeyka, Elham Khodayari Moez, Irina A. Dinu, Heather N. Switzer, Lisa K. Hornberger

Summary: In fetal transposition of the great arteries and hypoplastic left heart syndrome, a higher UA-PI in the third trimester, suggestive of placental insufficiency but not MCA-PI, is associated with worse 2-year growth and neurodevelopment outcomes.

CANADIAN JOURNAL OF CARDIOLOGY (2021)

Correction Cardiac & Cardiovascular Systems

Ventricular Arrhythmia and Life-Threatening Events in Patients With Repaired Tetralogy of Fallot (vol 132, pg 126, 2020)

Joseph Atallah, M. Cecilia Gonzalez Corcia, Edward P. Walsh

AMERICAN JOURNAL OF CARDIOLOGY (2021)

Article Cardiac & Cardiovascular Systems

Outcomes of Pediatric Patients With Defibrillators Following Initial Presentation With Sudden Cardiac Arrest

Jeffrey A. Robinson, Martin J. LaPage, Joseph Atallah, Gregory Webster, Christina Y. Miyake, Christopher Ratnasamy, Nicholas J. Ollberding, Shaun Mohan, Nicholas H. Von Bergen, Christopher L. Johnsrude, Jason M. Garnreiter, David S. Spar, Richard J. Czosek

Summary: ICD is recommended for secondary prevention after SCA, but its outcomes in pediatric patients remain unclear. The study found that pediatric patients receiving an ICD after SCA are at high risk for future device therapy, with factors such as genetic predisposition and cardiac function playing a role. Lack of a definitive diagnosis after SCA does not reduce the risk of subsequent events, highlighting the importance of continued prophylactic measures.

CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY (2021)

Article Cardiac & Cardiovascular Systems

Development and Evaluation of Decision Aids to Guide Families' Predictive Testing Choices for Children at Risk for Arrhythmia or Cardiomyopathy

Susan Christian, Alicia Welsh, Jeremy Yetman, Patrician Birch, Kirsten Bartels, Lindsay Burnell, Fiona Curtis, Cathleen Huculak, Laura Zahavich, Laura Arbour, Julien Marcadier, Joseph Atallah

Summary: This study developed and evaluated 4 cardiac decision aids for families with genetic diagnoses of certain heart conditions. The response to the aids was positive, with high acceptability and understandability scores. These tools can be used before, during, or after genetic counseling appointments to help guide discussions and provide a balanced approach to decision-making.

CANADIAN JOURNAL OF CARDIOLOGY (2021)

Article Cardiac & Cardiovascular Systems

Evaluation of age at symptom onset, proband status, and sex as predictors of disease severity in pediatric catecholaminergic polymorphic ventricular tachycardia

Dania Kallas, Thomas M. Roston, Sonia Franciosi, Laura Brett, Krystien V. V. Lieve, Sit-Yee Kwok, Prince J. Kannankeril, Andrew D. Krahn, Martin J. LaPage, Susan Etheridge, Allison Hill, Christopher Johnsrude, James Perry, Linda Knight, Peter Fischbach, Seshadri Balaji, Svjetlana Tisma-Dupanovic, Ian Law, Joseph Atallah, David Backhoff, Anna Kamp, Peter Kubus, Adam Kean, Peter F. Aziz, Joshua Kovach, Yung Lau, Jordana Kron, Sally-Ann Clur, Georgia Sarquella-Brugada, Arthur A. M. Wilde, Shubhayan Sanatani

Summary: In this study of pediatric CPVT patients, it was found that proband status is an independent predictor of time to first cardiac event. Age at symptom onset and sex were not identified as predictive factors. Treatment and strategies can influence event risk for both probands and relatives.

HEART RHYTHM (2021)

Review Cardiac & Cardiovascular Systems

Return of Results Policies for Genomic Research: Current Practices and the Hearts in Rhythm Organization (HiRO) Approach

Drake A. Comber, Brianna Davies, Jason D. Roberts, Rafik Tadros, Martin S. Green, Jeffrey S. Healey, Christopher S. Simpson, Shubhayan Sanatani, Christian Steinberg, Ciorsti MacIntyre, Paul Angaran, Henry Duff, Robert Hamilton, Laura Arbour, Richard Leather, Colette Seifer, Anne Fournier, Joseph Atallah, Shane Kimber, Bhavanesh Makanjee, Wael Alqarawi, Julia Cadrin-Tourigny, Jacqueline Joza, Karen Gibbs, Laura Robb, Laura Zahavich, Martin Gardner, Mario Talajic, Alice Virani, Andrew D. Krahn, Anna Lehman, Zachary W. M. Laksman

Summary: Research teams developing biobanks and genomic databases must establish policies for disclosing and reporting potentially actionable genomic results to research participants. There are various approaches to returning results, requiring decisions on informed consent, disclosure practices, and clinical validation.

CANADIAN JOURNAL OF CARDIOLOGY (2022)

Article Cardiac & Cardiovascular Systems

An International Multicenter Cohort Study on β-Blockers for the Treatment of Symptomatic Children With Catecholaminergic Polymorphic Ventricular Tachycardia

Puck J. Peltenburg, Dania Kallas, Johan M. Bos, Krystien V. V. Lieve, Sonia Franciosi, Thomas M. Roston, Isabelle Denjoy, Katrina B. Sorensen, Seiko Ohno, Ferran Roses-Noguer, Takeshi Aiba, Alice Maltret, Martin J. LaPage, Joseph Atallah, John R. Giudicessi, Sally-Ann B. Clur, Nico A. Blom, Michael Tanck, Fabrice Extramiana, Koichi Kato, Julien Barc, Martin Borggrefe, Elijah R. Behr, Georgia Sarquella-Brugada, Jacob Tfelt-Hansen, Esther Zorio, Heikki Swan, Janneke A. E. Kammeraad, Andrew D. Krahn, Andrew Davis, Frederic Sacher, Peter J. Schwartz, Jason D. Roberts, Jonathan R. Skinner, Maarten P. van den Berg, Prince J. Kannankeril, Fabrizio Drago, Tomas Robyns, Kristina Haugaa, Terezia Tavacova, Christopher Semsarian, Jan Till, Vincent Probst, Ramon Brugada, Wataru Shimizu, Minoru Horie, Antoine Leenhardt, Michael J. Ackerman, Shubhayan Sanatani, Christian van der Werf, Arthur A. M. Wilde

Summary: Selective beta-blockers are associated with a higher risk of arrhythmic events in symptomatic children with CPVT compared to nonselective beta-blockers, especially nadolol. Nadolol, or propranolol if nadolol is unavailable, should be the preferred beta-blocker for treating symptomatic children with CPVT.

CIRCULATION (2022)

Article Biochemistry & Molecular Biology

Identification and in-silico characterization of splice-site variants from a large cardiogenetic national registry

Kaveh Rayani, Brianna Davies, Matthew Cheung, Drake Comber, Jason D. Roberts, Rafik Tadros, Martin S. Green, Jeffrey S. Healey, Christopher S. Simpson, Shubhayan Sanatani, Christian Steinberg, Ciorsti MacIntyre, Paul Angaran, Henry Duff, Robert Hamilton, Laura Arbour, Richard Leather, Colette Seifer, Anne Fournier, Joseph Atallah, Shane Kimber, Bhavanesh Makanjee, Wael Alqarawi, Julia Cadrin-Tourigny, Jacqueline Joza, Martin Gardner, Mario Talajic, Richard D. Bagnall, Andrew D. Krahn, Zachary W. M. Laksman

Summary: Variants in splice sites of cardiac genes may increase the risk of potentially lethal arrhythmias. Screening of 1315 patients and relatives revealed that 10% of patients carried variants near the splice sites, and these variants were classified and evaluated using nine in silico tools. Among these tools, CADD showed good sensitivity, dbscSNV was highly sensitive, and SpliceAI exhibited high specificity. Splice variants remain an important consideration in inherited arrhythmia syndromes.

EUROPEAN JOURNAL OF HUMAN GENETICS (2023)

Article Cardiac & Cardiovascular Systems

Sex Differences and Utility of Treadmill Testing in Long-QT Syndrome

Lauren A. Yee, Hui-Chen Han, Brianna Davies, Charles M. Pearman, Zachary W. M. Laksman, Jason D. Roberts, Christian Steinberg, Rafik Tadros, Julia Cadrin-Tourigny, Christopher S. Simpson, Martin Gardner, Ciorsti MacIntyre, Laura Arbour, Richard Leather, Anne Fournier, Martin S. Green, Shane Kimber, Paul Angaran, Shubhayan Sanatani, Jacqueline Joza, Habib Khan, Jeffrey S. Healey, Joseph Atallah, Colette Seifer, Andrew D. Krahn

Summary: The study confirmed the high predictive value of the 3-step algorithm based on exercise response for diagnosing LQTS in a more representative population, with better accuracy in confirming the condition in female patients.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2022)

Article Cardiac & Cardiovascular Systems

Third Trimester Umbilical Arterial Pulsatility Index is Associated with Neurodevelopmental Outcomes at 2-Years in Major Congenital Heart Disease

Amol A. Moray, Charlene M. T. Robertson, Gwen Y. Bond, Jayani B. Abeysekera, Parsa Mohammadian, Irina A. Dinu, Joseph Atallah, Heather N. Switzer, Lisa K. Hornberger

Summary: This study examines the relationships between umbilical and middle cerebral artery pulsatility index (PI) in fetuses with major congenital heart disease (CHD) and neurodevelopment (ND) outcomes. The results show an inverse relationship between third trimester umbilical artery PI and cognitive, motor, and language domains of neurodevelopment at 2 years, indicating impaired neurodevelopment in these fetuses.

PEDIATRIC CARDIOLOGY (2023)

Article Psychology, Clinical

Leuprolide Acetate and QTc Interval in Gender-Diverse Youth

Richelle C. Waldner, Manpreet Doulla, Joseph Atallah, Sarah Rathwell, Chelsey Grimbly

Summary: This study aimed to determine the proportion of gender-diverse youth with QTc prolongation on leuprolide acetate therapy. A retrospective chart review revealed that none of the gender-diverse youth receiving leuprolide acetate therapy showed clinically significant QTc prolongation (QTc >460 milliseconds) at a tertiary care pediatric hospital in Alberta, Canada.

TRANSGENDER HEALTH (2023)

Article Cardiac & Cardiovascular Systems

Management of Inherited Arrhythmia Syndromes: A HiRO Consensus Handbook on Process of Care

Mikyla L. Janzen, Brianna Davies, Zachary W. M. Laksman, Jason D. Roberts, Shubhayan Sanatani, Christian Steinberg, Rafik Tadros, Julia Cadrin-Tourigny, Ciorsti Macintyre, Joseph Atallah, Anne Fournier, Martin S. Green, Robert Hamilton, Habib R. Khan, Shane Kimber, Steven White, Jacqueline Joza, Bhavanesh Makanjee, Erkan Ilhan, David Lee, Simon Hansom, Alexios Hadjis, Laura Arbour, Richard Leather, Colette Seifer, Paul Angaran, Christopher S. Simpson, Jeffrey S. Healey, Martin Gardner, Mario Talajic, Andrew D. Krahn

Summary: Inherited arrhythmia syndromes are rare genetic conditions that increase the risk of sudden cardiac arrest and death in seemingly healthy individuals. The Hearts in Rhythm Organization is a Canadian network that aims to improve care for patients and families affected by these conditions. This review provides consensus care pathways for common inherited cardiac conditions, as well as guidelines for investigating and managing sudden cardiac arrest and related cases.

CJC OPEN (2023)

Article Cardiac & Cardiovascular Systems

Conduction System Pacing Versus Conventional Cardiac Resynchronization Therapy in Congenital Heart Disease

Jeremy P. Moore, Natasja M. S. de Groot, Matthew Connor, Daniel Cortez, Jonathan Su, Austin Burrows, Kevin M. Shannon, Edward T. O. Leary, Maully Shah, Paul Khairy, Joseph Atallah, Tom Wong, Michael S. Lloyd, Yannick J. H. J. Taverne, Anne M. Dubin, Jens C. Nielsen, Reinder Evertz, Richard J. Czosek, Malini Madhavan, Philip M. Chang, Alper Aydin, Oscar Cano

Summary: This study compared the clinical outcomes of cardiac conduction system pacing (CSP) versus conventional cardiac resynchronization therapy (CRT) in congenital heart disease (CHD) patients with biventricular, systemic left ventricular anatomy. The results showed that CSP achieved similar improvement in left ventricular ejection fraction (LVEF) but greater QRS narrowing compared to conventional CRT.

JACC-CLINICAL ELECTROPHYSIOLOGY (2023)

Article Cardiac & Cardiovascular Systems

Evaluating the Prevalence and Factors Associated With an Optimal Neurodevelopmental Outcome in 4-to 6-Year-Old Children With Fontan Circulation

Michael Khoury, Morteza Hajihosseini, Charlene M. T. Robertson, Gwen Bond, Darren Freed, Irina Dinu, Sue Makarchuk, Ari Joffe, Joseph Atallah

Summary: This study aimed to evaluate the prevalence and factors associated with optimal neurodevelopmental outcomes in 4-to 6-year-old children with Fontan circulation. Factors such as female sex, years of maternal schooling, age at Fontan surgery, need for concomitant atrioventricular valve intervention, and time for lactate normalization were found to be associated with optimal neurodevelopmental outcomes.

CANADIAN JOURNAL OF CARDIOLOGY (2023)

Meeting Abstract Cardiac & Cardiovascular Systems

Relationship Between 3rd Trimester Umbilical Arterial Blood Flow and Neurodevelopmental Outcomes at 2 Years in Major Fetal Heart Disease

Amol Moray, Charlene Robertson, Gwen Bond, Jayani Abeysekera, Parsa Mohammadian, Irina Dinu, Joseph Atallah, Lisa K. Hornberger

CIRCULATION (2020)

No Data Available